Suppression of CPT‐1 activity facilitates increased ROS generation through impairment of NADPH, a potent nonenzymatic antioxidant in mitochondria, in human glioblastoma cells, and subsequently drives ATP depletion, finally inducing apoptosis cell death 40. The gene discussed is CPT2; the disease is glioblastoma.